Table 1.
Characteristics | LEPVI % (N) | No LEPVI % (N) | P-value |
---|---|---|---|
Total | 1.1 (2,887) | 98.9% (253,644) | |
Age, mean (SD) | 33.55 (4.97) | 31.49 (5.59) | <0.001 |
Smoking (%) | 7.9 (229) | 6.6 (16,812) | 0.006 |
Obesity (%) | 2,8 (80) | 1.7 (4,287) | <0.001 |
Hypertension (%) | 2.7 (77) | 2.7 (6,725) | 0.95 |
Diabetes (5) | 5.7 (164) | 5.3 (13,491) | 0.38 |
Asthma (%) | 2.3 (67) | 1.7 (4,392) | 0.015 |
Hypothyroidism (%) | 7.7 (227) | 6.5 (16,610) | 0.022 |
Coagulopathy Disorder (%) | 1.0 (29) | 0.5 (1,383) | 0.002 |
Anemia | 1.9 (54) | 1.4 (3,564) | 0.039 |
Charlson index score (%) | |||
0 1 2 |
96.8 (2,795) 3.1 (89) 0.1 (3) |
97.4 (247,163) 2.4 (6,207) 0.1 (274) |
0.090 |
Myocardial infarction, congestive heart failure, cerebrovascular disease, peripheral arteriovascular disorders, paralysis, renal disease, liver disease, rheumatic disease, AIDS/HIV, peptic ulcer disease excluding bleeding, depression, dementia, alcohol and drugs consumption are <1% in both groups. None of them were statistically significant. P-values were obtained from chi-squared statistics with the exception of the one for age (t-test). LEPVI, varicose veins in lower extremities and/or pelvis; N, number of patients; %, percentage; SD, standard deviation.